Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Hedge Funds Bet Big On Johnson & Johnson: Top Healthcare Stock to Watch

November 30, 2024
Hedge funds have made a significant investment in Johnson & Johnson (JNJ), making it a top healthcare stock to watch. With its strong track record and promising future, JNJ has attracted the attention of these major players in the financial industry. The company's diverse portfolio, which includes pharmaceuticals, medical devices, and consumer health products, provides a stable foundation for growth and profitability. Investors are encouraged to consider buying JNJ stocks and seeking the professional advice of Stocks Prognosis for forecasts on its movement in the market.
If you want to leave a comment, then you need Login or Register





Other data for JNJ

Related data

JNJAugust 10, 2025Johnson & Johnson: How Investors May Respond To JNJ Talc Verdict and New Medical Innovations  ~1 min.

Johnson & Johnson, a global healthcare company, has recently been in the spotlight due to controversies surrounding their talc products....


JNJJuly 14, 2025Johnson & Johnson Innovates with New Product Launches  ~1 min.

Johnson & Johnson, a leading pharmaceutical company, continues to make waves in the industry with its latest submission of sNDA for the schizophrenia drug CAPLYTA to the FDA....


JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....


JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....


JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....


JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....


JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....


JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....


JNJFebruary 28, 2025Johnson & Johnson's Strong Performance Since Last Earnings Report Raises Expectations  ~1 min.

Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report....


JNJFebruary 26, 2025The surgical devices I design for JJ speed healing and save lives  ~1 min.

Johnson & Johnson (JNJ) has been at the forefront of medical technology, constantly innovating and developing breakthrough surgical devices that not only speed up the healing process but also save lives....


REGNFebruary 9, 2025Regeneron Pharmaceuticals Inc REGN Reports Strong Earnings in Q4 2024  ~2 min.

Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....


ABBVNovember 27, 2024AbbVie Executives to Present at Citi's 2024 Global Healthcare Conference  ~1 min.

AbbVie Inc. (ABBV) has announced that its executives will be presenting at Citi's 2024 Global Healthcare Conference....


REGNFebruary 10, 2025Regeneron Pharmaceuticals Inc REGN Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... Yahoo Finance  ~1 min.

Regeneron Pharmaceuticals Inc. (REGN) recently held its Q4 2024 earnings call, highlighting strong revenue growth and positive developments in its portfolio....


ABBVNovember 26, 2024AbbVie Inc. Executes Impressive Performance at Citis 2024 Global Healthcare Conference  ~1 min.

AbbVie Inc., a leading pharmaceutical company, recently showcased its strong growth potential and innovative product portfolio at the Citis 2024 Global Healthcare Conference....


BMYJanuary 4, 2025Bristol-Myers Squibb Company to Expand its Healthcare Offerings at J.P. Morgan Conference  ~1 min.

Bristol-Myers Squibb Company (BMY) is set to present at J.P. Morgan's 43rd Annual Healthcare Conference, showcasing its latest advancements and achievements in the pharmaceutical industry....